{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:42:53Z","timestamp":1791474173239,"version":"4.3.4"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,2]],"date-time":"2022-10-02T00:00:00Z","timestamp":1664668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,2]],"date-time":"2022-10-02T00:00:00Z","timestamp":1664668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2017YFA0103500"],"award-info":[{"award-number":["2017YFA0103500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2021YFA1101000"],"award-info":[{"award-number":["2021YFA1101000"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Regen"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Vitiligo is the most common human skin depigmenting disorder. It is mediated by endogenous autoreactive CD8\u2009+\u2009T cells that destruct skin melanocytes. This disease has an estimated prevalence of 1% of the global population and currently has no cure. Animal models are indispensable tools for understanding vitiligo pathogenesis and for developing new therapies. Here, we describe a vitiligo mouse model which recapitulates key clinical features of vitiligo, including epidermis depigmentation, CD8\u2009+\u2009T cell infiltration in skin, and melanocyte loss. To activate endogenous autoreactive cytotoxic CD8\u2009+\u2009T cells targeting melanocytes, this model relies on transient inoculation of B16F10 melanoma cells and depletion of CD4\u2009+\u2009regulatory T cells. At cellular level, epidermal CD8\u2009+\u2009T cell infiltration and melanocyte loss start as early as Day 19 after treatment. Visually apparent epidermis depigmentation occurs 2\u00a0months later. This protocol can efficiently induce vitiligo in any C57BL\/6 background mouse strain, using only commercially available reagents. This enables researchers to carry out in-depth in vivo vitiligo studies utilizing mouse genetics tools, and provides a powerful platform for drug discovery.<\/jats:p>","DOI":"10.1186\/s13619-022-00132-9","type":"journal-article","created":{"date-parts":[[2022,10,2]],"date-time":"2022-10-02T01:03:11Z","timestamp":1664672591000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["A mouse model of vitiligo based on endogenous auto-reactive CD8\u2009+\u2009T cell targeting skin melanocyte"],"prefix":"10.1186","volume":"11","author":[{"given":"Daoming","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7404-4538","authenticated-orcid":false,"given":"Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,2]]},"reference":[{"key":"132_CR1","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/jid.2010.337","volume":"131","author":"SA Birlea","year":"2011","unstructured":"Birlea SA, Jin Y, Bennett DC, Herbstman DM, Wallace MR, Mccormack WT, Helen Kemp E, Gawkrodger DJ, Weetman AP, Picardo M, et al. Comprehensive association analysis of candidate genes for generalized vitiligo supports XBP1, FOXP3, and TSLP. J Invest Dermatol. 2011;131:371\u201381.","journal-title":"J Invest Dermatol"},{"key":"132_CR2","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jid.2017.08.038","volume":"138","author":"K Boniface","year":"2018","unstructured":"Boniface K, Jacquemin C, Darrigade A-S, Dessarthe B, Martins C, Boukhedouni N, Vernisse C, Grasseau A, Thiolat D, Rambert J, et al. Vitiligo skin is imprinted with resident memory CD8 T cells expressing CXCR3. J Invest Dermatol. 2018;138:355\u201364.","journal-title":"J Invest Dermatol"},{"key":"132_CR3","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1172\/JCI44849","volume":"121","author":"KT Byrne","year":"2011","unstructured":"Byrne KT, C\u00f4t\u00e9 AL, Zhang P, Steinberg SM, Guo Y, Allie R, Zhang W, Ernstoff MS, Usherwood EJ, Turk M. Autoimmune melanocyte destruction is required for robust CD8+ memory T cell responses to mouse melanoma. J Clin Invest. 2011;121:1797\u2013809.","journal-title":"J Clin Invest"},{"key":"132_CR4","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/jid.2013.540","volume":"134","author":"S Chatterjee","year":"2014","unstructured":"Chatterjee S, Eby JM, Al-Khami AA, Soloshchenko M, Kang H-K, Kaur N, Naga OS, Murali A, Nishimura MI, Caroline Le Poole I, Mehrotra S. A quantitative increase in regulatory T cells controls development of Vitiligo. J Invest Dermatol. 2014;134:1285\u201394.","journal-title":"J Invest Dermatol"},{"key":"132_CR5","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nature10940","volume":"485","author":"T Chen","year":"2012","unstructured":"Chen T, Heller E, Beronja S, Oshimori N, Stokes N, Fuchs E. An RNA interference screen uncovers a new molecule in stem cell self-renewal and long-term regeneration. Nature. 2012;485:104\u20138.","journal-title":"Nature"},{"key":"132_CR6","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.tcb.2014.10.001","volume":"25","author":"RR Driskell","year":"2015","unstructured":"Driskell RR, Watt FM. Understanding fibroblast heterogeneity in the skin. Trends Cell Biol. 2015;25:92\u20139.","journal-title":"Trends Cell Biol"},{"key":"132_CR7","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/pcmr.12105","volume":"26","author":"M Dwivedi","year":"2013","unstructured":"Dwivedi M, Laddha NC, Arora P, Marfatia YS, Begum R. Decreased regulatory T-cells and CD4+\/CD8+ratio correlate with disease onset and progression in patients with generalized vitiligo. Pigment Cell Melanoma Res. 2013;26:586\u201391.","journal-title":"Pigment Cell Melanoma Res"},{"key":"132_CR8","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1111\/pcmr.12284","volume":"27","author":"JM Eby","year":"2014","unstructured":"Eby JM, Kang H-K, Klarquist J, Chatterjee S, Mosenson JA, Nishimura MI, Garrett-Mayer E, Longley BJ, Engelhard VH, Mehrotra S, Le Poole IC. Immune responses in a mouse model of vitiligo with spontaneous epidermal de- and repigmentation. Pigment Cell Melanoma Res. 2014;27:1075\u201385.","journal-title":"Pigment Cell Melanoma Res"},{"key":"132_CR9","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1038\/jid.2015.26","volume":"135","author":"JM Eby","year":"2015","unstructured":"Eby JM, Kang H-K, Tully ST, Bindeman WE, Peiffer DS, Chatterjee S, Mehrotra S, Caroline Le Poole I. CCL22 to activate treg migration and suppress depigmentation in Vitiligo. J Invest Dermatol. 2015;135:1574\u201380.","journal-title":"J Invest Dermatol"},{"key":"132_CR10","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1111\/j.1755-148X.2012.00997.x","volume":"25","author":"K Ezzedine","year":"2012","unstructured":"Ezzedine K, Lim HW, Suzuki T, Katayama I, Hamzavi I, Lan CCE, Goh BK, Anbar T, Silva De Castro C, Lee AY, et al. Revised classification\/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference. Pigment Cell Melanoma Res. 2012;25:E1\u201313.","journal-title":"Pigment Cell Melanoma Res"},{"issue":"22","key":"132_CR11","doi-asserted-by":"publisher","first-page":"5731","DOI":"10.3390\/ijms20225731","volume":"20","author":"CM Failla","year":"2019","unstructured":"Failla CM, Carbone ML, Fortes C, Pagnanelli G, D\u2019Atri S. Melanoma and Vitiligo: In Good Company. Int J Mol Sci. 2019;20(22):5731.","journal-title":"Int J Mol Sci"},{"key":"132_CR12","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.4049\/jimmunol.0902778","volume":"184","author":"RK Gregg","year":"2010","unstructured":"Gregg RK, Nichols L, Chen Y, Lu B, Engelhard VH. Mechanisms of spatial and temporal development of autoimmune vitiligo in tyrosinase-specific TCR transgenic mice. J Immunol. 2010;184:1909\u201317.","journal-title":"J Immunol"},{"issue":"1","key":"132_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12955-020-1278-7","volume":"18","author":"N Hamidizadeh","year":"2020","unstructured":"Hamidizadeh N, Ranjbar S, Ghanizadeh A, Parvizi MM, Jafari P, Handjani F. Evaluating prevalence of depression, anxiety and hopelessness in patients with vitiligo on an Iranian population. Health Qual Life Outcomes. 2020;18(1):20.","journal-title":"Health Qual Life Outcomes"},{"key":"132_CR14","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.det.2016.11.006","volume":"35","author":"JE Harris","year":"2017","unstructured":"Harris JE. Chemical-induced vitiligo. Dermatol Clin. 2017;35:151\u201361.","journal-title":"Dermatol Clin"},{"key":"132_CR15","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/jid.2011.463","volume":"132","author":"JE Harris","year":"2012","unstructured":"Harris JE, Harris TH, Weninger W, Wherry EJ, Hunter CA, Turka LA. A mouse model of vitiligo with focused epidermal depigmentation requires IFN-gamma for autoreactive CD8(+) T-cell accumulation in the skin. J Invest Dermatol. 2012;132:1869\u201376.","journal-title":"J Invest Dermatol"},{"key":"132_CR16","first-page":"1","volume":"2015","author":"DS Hegab","year":"2015","unstructured":"Hegab DS, Attia MAS. Decreased circulating T regulatory cells in Egyptian patients with Nonsegmental Vitiligo: correlation with disease activity. Dermatol Res Pract. 2015;2015:1\u20137.","journal-title":"Dermatol Res Pract"},{"key":"132_CR17","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.clim.2016.07.006","volume":"172","author":"B Herzberg","year":"2016","unstructured":"Herzberg B, Fisher DE. Metastatic melanoma and immunotherapy. Clin Immunol. 2016;172:105\u201310.","journal-title":"Clin Immunol"},{"key":"132_CR18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1001\/jamadermatol.2015.2707","volume":"152","author":"C Hua","year":"2016","unstructured":"Hua C, Boussemart L, Mateus C, Routier E, Boutros C, Cazenave H, Viollet R, Thomas M, Roy S, Benannoune N, et al. Association of vitiligo with tumor response in patients with metastatic melanoma treated with Pembrolizumab. JAMA Dermatol. 2016;152:45\u201351.","journal-title":"JAMA Dermatol"},{"key":"132_CR19","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1056\/NEJMoa061592","volume":"356","author":"Y Jin","year":"2007","unstructured":"Jin Y, Mailloux CM, Gowan K, Riccardi SL, LaBerge G, Bennett DC, Fain PR, Spritz RA. NALP1 in vitiligo-associated multiple autoimmune disease. N Engl J Med. 2007;356:1216\u201325.","journal-title":"N Engl J Med"},{"key":"132_CR20","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1056\/NEJMoa0908547","volume":"362","author":"Y Jin","year":"2010","unstructured":"Jin Y, Birlea SA, Fain PR, Gowan K, Riccardi SL, Holland PJ, Mailloux CM, Sufit AJD, Hutton SM, Amadi-Myers A, et al. Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo. N Engl J Med. 2010;362:1686\u201397.","journal-title":"N Engl J Med"},{"key":"132_CR21","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/ng.2272","volume":"44","author":"Y Jin","year":"2012","unstructured":"Jin Y, Birlea SA, Fain PR, Ferrara TM, Ben S, Riccardi SL, Cole JB, Gowan K, Holland PJ, Bennett DC, et al. Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo. Nat Genet. 2012;44:676\u201380.","journal-title":"Nat Genet"},{"key":"132_CR22","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1038\/ng.3680","volume":"48","author":"Y Jin","year":"2016","unstructured":"Jin Y, Andersen G, Yorgov D, Ferrara TM, Ben S, Brownson KM, Holland PJ, Birlea SA, Siebert J, Hartmann A, et al. Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants. Nat Genet. 2016;48:1418\u201324.","journal-title":"Nat Genet"},{"key":"132_CR23","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/j.1755-148X.2010.00688.x","volume":"23","author":"J Klarquist","year":"2010","unstructured":"Klarquist J, Denman CJ, Hernandez C, Wainwright DJ, Strickland FM, Overbeck A, Mehrotra S, Nishimura MI, Le Poole IC. Reduced skin homing by functional Treg in vitiligo. Pigment Cell Melanoma Res. 2010;23:276\u201386.","journal-title":"Pigment Cell Melanoma Res"},{"key":"132_CR24","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1111\/j.1365-4632.2011.05377.x","volume":"51","author":"C Kruger","year":"2012","unstructured":"Kruger C, Schallreuter KU. A review of the worldwide prevalence of vitiligo in children\/adolescents and adults. Int J Dermatol. 2012;51:1206\u201312.","journal-title":"Int J Dermatol"},{"key":"132_CR25","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1097\/QAD.0000000000001047","volume":"30","author":"A Kumar","year":"2016","unstructured":"Kumar A, Dogra S, Gupta A, Suri D. Treatment of vitiligo with antiretroviral therapy in a child with HIV infection. AIDS. 2016;30:1309\u201310.","journal-title":"AIDS"},{"issue":"581","key":"132_CR26","doi-asserted-by":"publisher","first-page":"eabd8636","DOI":"10.1126\/scitranslmed.abd8636","volume":"13","author":"JA Lo","year":"2021","unstructured":"Lo JA, Kawakubo M, Juneja VR, Su MY, Erlich TH, LaFleur MW, Kemeny LV, Rashid M, Malehmir M, Rabi SA, et al. Epitope spreading toward wild-type melanocyte-lineage antigens rescues suboptimal immune checkpoint blockade responses. Sci Transl Med. 2021;13(581):eabd8636.","journal-title":"Sci Transl Med"},{"key":"132_CR27","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1126\/science.aaa1292","volume":"346","author":"Y Maeda","year":"2014","unstructured":"Maeda Y, Nishikawa H, Sugiyama D, Ha D, Hamaguchi M, Saito T, Nishioka M, Wing JB, Adeegbe D, Katayama I, Sakaguchi S. Detection of self-reactive CD8+ T cells with an anergic phenotype in healthy individuals. Science. 2014;346:1536\u201340.","journal-title":"Science"},{"issue":"10","key":"132_CR28","doi-asserted-by":"publisher","first-page":"eaam6346","DOI":"10.1126\/sciimmunol.aam6346","volume":"2","author":"BT Malik","year":"2017","unstructured":"Malik BT, Byrne KT, Vella JL, Zhang P, Shabaneh TB, Steinberg SM, Molodtsov AK, Bowers JS, Angeles CV, Paulos CM, et al. Resident memory T cells in the skin mediate durable immunity to melanoma. Sci Immunol. 2017;2(10):eaam6346.","journal-title":"Sci Immunol"},{"key":"132_CR29","doi-asserted-by":"publisher","first-page":"6253","DOI":"10.4049\/jimmunol.169.11.6253","volume":"169","author":"S Mantovani","year":"2002","unstructured":"Mantovani S, Palermo B, Garbelli S, Campanelli R, Robustelli Della Cuna G, Gennari R, Benvenuto F, Lantelme E, Giachino C. Dominant TCR-alpha requirements for a self antigen recognition in humans. J Immunol. 2002;169:6253\u201360.","journal-title":"J Immunol"},{"key":"132_CR30","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1038\/s41598-018-19407-w","volume":"8","author":"X Miao","year":"2018","unstructured":"Miao X, Xu R, Fan B, Chen J, Li X, Mao W, Hua S, Li B. PD-L1 reverses depigmentation in Pmel-1 vitiligo mice by increasing the abundance of Tregs in the skin. Sci Rep. 2018;8:1605.","journal-title":"Sci Rep"},{"key":"132_CR31","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/j.1755-148X.2011.00916.x","volume":"25","author":"JA Mosenson","year":"2012","unstructured":"Mosenson JA, Zloza A, Klarquist J, Barfuss AJ, Guevara-Patino JA, Poole IC. HSP70i is a critical component of the immune response leading to vitiligo. Pigment Cell Melanoma Res. 2012;25:88\u201398.","journal-title":"Pigment Cell Melanoma Res"},{"key":"132_CR32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1046\/j.0022-202x.2001.01377.x","volume":"117","author":"S Muller-Rover","year":"2001","unstructured":"Muller-Rover S, Handjiski B, van der Veen C, Eichmuller S, Foitzik K, McKay IA, Stenn KS, Paus R. A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages. J Investig Dermatol. 2001;117:3\u201315.","journal-title":"J Investig Dermatol"},{"key":"132_CR33","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.jaad.2019.11.017","volume":"82","author":"C Nardin","year":"2020","unstructured":"Nardin C, Jeand\u2019Heur A, Bouiller K, Valnet-Rabier MB, Dresco F, Castagna J, Mareschal A, Carlet C, Nerich V, Limat S, et al. Vitiligo under anti\u2013programmed cell death-1 therapy is associated with increased survival in melanoma patients. J Am Acad Dermatol. 2020;82:770\u20132.","journal-title":"J Am Acad Dermatol"},{"key":"132_CR34","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1084\/jem.188.6.1203","volume":"188","author":"GS Ogg","year":"1998","unstructured":"Ogg GS, Dunbar PR, Romero P, Chen JL, Cerundolo V. High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo. J Exp Med. 1998;188:1203\u20138.","journal-title":"J Exp Med"},{"key":"132_CR35","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1046\/j.1523-1747.2001.01408.x","volume":"117","author":"B Palermo","year":"2001","unstructured":"Palermo B, Campanelli R, Garbelli S, Mantovani S, Lantelme E, Brazzelli V, Ardig\u00f3 M, Borroni G, Martinetti M, Badulli C, et al. Specific cytotoxic T lymphocyte responses against Melan-A\/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex\/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo. J Invest Dermatol. 2001;117:326\u201332.","journal-title":"J Invest Dermatol"},{"key":"132_CR36","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1002\/eji.200535110","volume":"35","author":"B Palermo","year":"2005","unstructured":"Palermo B, Garbelli S, Mantovani S, Scoccia E, Da Prada GA, Bernabei P, Avanzini MA, Brazzelli V, Borroni G, Giachino C. Qualitative difference between the cytotoxic T lymphocyte responses to melanocyte antigens in melanoma and vitiligo. Eur J Immunol. 2005;35:3153\u201362.","journal-title":"Eur J Immunol"},{"key":"132_CR37","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.jaad.2014.07.050","volume":"71","author":"A Paradisi","year":"2014","unstructured":"Paradisi A, Tabolli S, Didona B, Sobrino L, Russo N, Abeni D. Markedly reduced incidence of melanoma and nonmelanoma skin cancer in a nonconcurrent cohort of 10,040 patients with vitiligo. J Am Acad Dermatol. 2014;71:1110\u20136.","journal-title":"J Am Acad Dermatol"},{"key":"132_CR38","doi-asserted-by":"publisher","first-page":"6","DOI":"10.5070\/D374H8T36W","volume":"18","author":"RC Philips","year":"2012","unstructured":"Philips RC, Motaparthi K, Krishnan B, Hsu S. HIV photodermatitis presenting with widespread vitiligo-like depigmentation. Dermatol Online J. 2012;18:6.","journal-title":"Dermatol Online J"},{"key":"132_CR39","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1080\/08916930500050368","volume":"38","author":"R Pichler","year":"2005","unstructured":"Pichler R, Sfetsos K, Aubock J, Badics B, Gutenbrunner S, Berg J. Cytomegalovirus infection in central European vitiligo patients? Autoimmunity. 2005;38:121\u20132.","journal-title":"Autoimmunity"},{"key":"132_CR40","first-page":"1636","volume":"40","author":"G Poste","year":"1980","unstructured":"Poste G, Doll J, Hart IR, Fidler IJ. In vitro selection of murine B16 melanoma variants with enhanced tissue-invasive properties. Cancer Res. 1980;40:1636\u201344.","journal-title":"Cancer Res"},{"issue":"6","key":"132_CR41","doi-asserted-by":"publisher","first-page":"e1000523","DOI":"10.1371\/journal.pgen.1000523","volume":"5","author":"Y Ren","year":"2009","unstructured":"Ren Y, Yang S, Xu S, Gao M, Huang W, Gao T, Fang Q, Quan C, Zhang C, Sun L, et al. Genetic variation of promoter sequence modulates XBP1 expression and genetic risk for vitiligo. PLoS Genet. 2009;5(6):e1000523.","journal-title":"PLoS Genet"},{"key":"132_CR42","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/j.0736-8046.2004.21512.x","volume":"21","author":"D Seckin","year":"2004","unstructured":"Seckin D, Durusoy C, Sahin S. Concomitant vitiligo and psoriasis in a patient treated with interferon alfa-2a for chronic Hepatitis B infection. Pediatr Dermatol. 2004;21:577\u20139.","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"132_CR43","doi-asserted-by":"publisher","first-page":"149","DOI":"10.4103\/0378-6323.32708","volume":"73","author":"V Sehgal","year":"2007","unstructured":"Sehgal V, Srivastava G. Vitiligo: Compendium of clinico-epidemiological features. Indian J Dermatol Venereol Leprol. 2007;73(3):149\u201356.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"132_CR44","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s13671-014-0098-6","volume":"4","author":"NB Silverberg","year":"2015","unstructured":"Silverberg NB. The epidemiology of Vitiligo. Curr Dermatol Rep. 2015;4:36\u201343.","journal-title":"Curr Dermatol Rep"},{"key":"132_CR45","first-page":"255","volume":"95","author":"JI Silverberg","year":"2015","unstructured":"Silverberg JI, Silverberg NB. Vitiligo disease triggers: psychological stressors preceding the onset of disease. Cutis. 2015;95:255\u201362.","journal-title":"Cutis"},{"key":"132_CR46","doi-asserted-by":"publisher","first-page":"5736","DOI":"10.1158\/1078-0432.CCR-11-0230","volume":"17","author":"EPM Tjin","year":"2011","unstructured":"Tjin EPM, Konijnenberg D, Krebbers G, Mallo H, Drijfhout JW, Franken KLMC, Van Der Horst CMAM, Bos JD, Nieweg OE, Kroon BBR, et al. T-Cell immune function in tumor, skin, and peripheral blood of advanced stage melanoma patients: implications for immunotherapy. Clin Cancer Res. 2011;17:5736\u201347.","journal-title":"Clin Cancer Res"},{"key":"132_CR47","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1038\/jid.2009.32","volume":"129","author":"JG Van den Boorn","year":"2009","unstructured":"Van den Boorn JG, Konijnenberg D, Dellemijn TA, van der Veen JP, Bos JD, Melief CJ, Vyth-Dreese FA, Luiten RM. Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients. J Invest Dermatol. 2009;129:2220\u201332.","journal-title":"J Invest Dermatol"},{"key":"132_CR48","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1097\/01.LAB.0000069521.42488.1B","volume":"83","author":"A Wankowicz-Kalinska","year":"2003","unstructured":"Wankowicz-Kalinska A, van den Wijngaard R, Tigges BJ, Westerhof W, Ogg GS, Cerundolo V, Storkus WJ, Das PK. Immunopolarization of CD4+ and CD8+ T cells to type-1-like is associated with melanocyte loss in human vitiligo. Lab Invest. 2003;83:683\u201395.","journal-title":"Lab Invest"},{"key":"132_CR49","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3892\/mmr.2012.1117","volume":"7","author":"J Wu","year":"2013","unstructured":"Wu J, Zhou M, Wan Y, Xu AIE. CD8+ T cells from vitiligo perilesional margins induce autologous melanocyte apoptosis. Mol Med Report. 2013;7:237\u201341.","journal-title":"Mol Med Report"},{"key":"132_CR50","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41586-021-04221-8","volume":"601","author":"Z Xu","year":"2022","unstructured":"Xu Z, Chen D, Hu Y, Jiang K, Huang H, Du Y, Wu W, Wang J, Sui J, Wang W, et al. Anatomically distinct fibroblast subsets determine skin autoimmune patterns. Nature. 2022;601:118\u201324.","journal-title":"Nature"},{"key":"132_CR51","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.stem.2018.07.016","volume":"23","author":"Z Yu","year":"2018","unstructured":"Yu Z, Jiang K, Xu Z, Huang H, Qian N, Lu Z, Chen D, Di R, Yuan T, Du Z, et al. Hoxc-dependent mesenchymal niche heterogeneity drives regional hair follicle regeneration. Cell Stem Cell. 2018;23:487-500.e486.","journal-title":"Cell Stem Cell"},{"key":"132_CR52","doi-asserted-by":"publisher","first-page":"6468","DOI":"10.1158\/0008-5472.CAN-07-1264","volume":"67","author":"P Zhang","year":"2007","unstructured":"Zhang P, C\u00f4t\u00e9 AL, Vries VCd, Usherwood EJ, Turk M. Induction of postsurgical tumor immunity and T-cell memory by a poorly immunogenic tumor. Cancer Res. 2007;67:6468\u201376.","journal-title":"Cancer Res"},{"key":"132_CR53","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/exd.12184","volume":"22","author":"Y Zhu","year":"2013","unstructured":"Zhu Y, Wang S, Xu A. A mouse model of vitiligo induced by monobenzone. Exp Dermatol. 2013;22:499\u2013501.","journal-title":"Exp Dermatol"}],"container-title":["Cell Regeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13619-022-00132-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13619-022-00132-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13619-022-00132-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,2]],"date-time":"2022-10-02T01:03:21Z","timestamp":1664672601000},"score":1,"resource":{"primary":{"URL":"https:\/\/cellregeneration.springeropen.com\/articles\/10.1186\/s13619-022-00132-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,2]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["132"],"URL":"https:\/\/doi.org\/10.1186\/s13619-022-00132-9","relation":{},"ISSN":["2045-9769"],"issn-type":[{"value":"2045-9769","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,2]]},"assertion":[{"value":"24 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Committee on the Ethics of Animal Experiments of the National Institute of Biological Sciences\u00a0(NIBS2022M0020), Beijing.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Ting Chen is a member of the Editorial Board for Cell Regeneration. She was not involved in the journal's review of, or decisions related to this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31"}}